CJC-1295 & Ipamorelin: A Research Peptide Overview
Share
CJC-1295 and Ipamorelin are two growth-hormone secretagogue research peptides that are frequently studied together. This overview explains each compound, why they're often paired, and how to source them.
What is CJC-1295?
CJC-1295 (No DAC), also known as Modified GRF (1-29), is a synthetic GHRH (growth-hormone-releasing hormone) analog. It is studied for its activity at the GHRH receptor.
What is Ipamorelin?
Ipamorelin is a selective synthetic pentapeptide GHRP (growth-hormone-releasing peptide), studied as a ghrelin/GHS-R1a receptor agonist. Its selectivity makes it a common reference compound in secretagogue research.
Why they're studied together
CJC-1295 and Ipamorelin act on two different receptor pathways (GHRH vs. GHS-R), so they're frequently researched as a pair to study complementary secretagogue signaling. That's why we offer a combined blend in addition to the single compounds.
Formats & products
All sit within the Anti-Aging & Longevity collection, alongside related GHRH analogs Sermorelin and Tesamorelin.
Handling, reconstitution & purity
Reconstitute lyophilized vials with bacteriostatic water per our reconstitution guide. All material is ≥98% HPLC-verified, documented on the Quality & COA page.
Manufacturing & Quality
Alpha Biologix manufactures both CJC-1295 and Ipamorelin under pharmaceutical-grade manufacturing standards. Every batch — single compound or blend — is verified to ≥98% HPLC purity, independently tested by third-party laboratories, and backed by a Certificate of Analysis (COA) available per batch.
All products and information are provided for laboratory and research use only. Not for human or veterinary use, diagnostic, or therapeutic application. No medical claims are made.